116 related articles for article (PubMed ID: 34839935)
1. A nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems.
Hue JJ; Katayama ES; Markt SC; Elshami M; Saltzman J; Bajor D; Hosmer A; Mok S; Dumot J; Ammori JB; Rothermel LD; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2022 Jul; 172(1):257-264. PubMed ID: 34839935
[TBL] [Abstract][Full Text] [Related]
2. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
[TBL] [Abstract][Full Text] [Related]
4. A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment.
Elshami M; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Chavin KD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 Aug; 24(8):1280-1290. PubMed ID: 35063353
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
6. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
7. Racial and Socioeconomic Disparities in the Treatments and Outcomes of Pancreatic Cancer Among Different Treatment Facility Types.
Zhu F; Wang H; Ashamalla H
Pancreas; 2020; 49(10):1355-1363. PubMed ID: 33122525
[TBL] [Abstract][Full Text] [Related]
8. Differences in Baseline Characteristics and White Blood Cell Ratios Between Racial Groups in Patients with Pancreatic Adenocarcinoma.
Ueberroth BE; Khan A; Zhang KJ; Philip PA
J Gastrointest Cancer; 2021 Mar; 52(1):160-168. PubMed ID: 32077005
[TBL] [Abstract][Full Text] [Related]
9. Ethnic and racial disparities of pancreatic adenocarcinoma in Florida.
Fagenson AM; Grossi SM; Musgrove K; Solomon N; de la Vega PR; Castro G; Pitt HA; Varella M; Zavallos J; Acuna J
HPB (Oxford); 2020 May; 22(5):735-743. PubMed ID: 31601507
[TBL] [Abstract][Full Text] [Related]
10. Access Denied: Inequities in Clinical Trial Enrollment for Pancreatic Cancer.
Eskander MF; Gil L; Beal EW; Li Y; Hamad A; Oppong B; Obeng-Gyasi S; Tsung A
Ann Surg Oncol; 2022 Feb; 29(2):1271-1277. PubMed ID: 34655352
[TBL] [Abstract][Full Text] [Related]
11. A multi-institutional study of pancreatic cancer in Harris County, Texas: race predicts treatment and survival.
Wray CJ; Castro-Echeverry E; Silberfein EJ; Ko TC; Kao LS
Ann Surg Oncol; 2012 Sep; 19(9):2776-81. PubMed ID: 22526908
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
13. Persistence of racial disparities in early-stage lung cancer treatment.
Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
[TBL] [Abstract][Full Text] [Related]
14. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.
Tohme S; Kaltenmeier C; Bou-Samra P; Varley PR; Tsung A
Ann Surg Oncol; 2018 Nov; 25(12):3427-3435. PubMed ID: 30043318
[TBL] [Abstract][Full Text] [Related]
15. Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.
Riner AN; Girma S; Vudatha V; Mukhopadhyay N; Skoro N; Gal TS; Freudenberger DC; Herremans KM; George TJ; Trevino JG
J Clin Oncol; 2022 Jul; 40(20):2193-2202. PubMed ID: 35316089
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in young women with endometrial cancer.
Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
18. Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Survival in Wisconsin.
Schiefelbein AM; Krebsbach JK; Taylor AK; Zhang J; Haimson CE; Trentham-Dietz A; Skala MC; Eason JM; Weber SM; Varley PR; Zafar SN; LoConte NK
WMJ; 2022 Jul; 121(2):77-93. PubMed ID: 35857681
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
Singal V; Singal AK; Kuo YF
J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
[TBL] [Abstract][Full Text] [Related]
20. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]